Clinical Trials Logo

Milignant Gliomas clinical trials

View clinical trials related to Milignant Gliomas.

Filter by:
  • None
  • Page 1

NCT ID: NCT02494804 Not yet recruiting - Clinical trials for Cytokine-Induced Killer Cells

Effect of Cytokine-induced Killer Cells for Stage I-II Malignant Gliomas

Start date: July 2015
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine whether combining of Temozolomide and cytokine-induced killer cells (CIK) transfusion can prolong survival of patients with Malignant Gliomas. The effectiveness and safety of CIK cells for the treatment of Malignant Glioma is also evaluated.